Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/09/036920
CTRI/2021/09/036920
Not yet recruiting
未知

Comparison of terlipressin infusion versus noradrenaline in septic shock in patients with acute on chronic liver failure.

Pt BD Sharma Pgims rohtak0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K768- Other specified diseases of liver

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K768- Other specified diseases of liver
Sponsor
Pt BD Sharma Pgims rohtak
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Pt BD Sharma Pgims rohtak

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients between age 18 to 70 years.
  • •2\. Patients of Acute\-on\-chronic liver failure with sepsis in septic shock.
  • •3\. Patients who gives informed consent and in case patient is not in fully coherent state,consent given by first degree relative shall be taken.

Exclusion Criteria

  • •1\. Patients with any chronic respiratory disease, chronic kidney disease.
  • •2\. History of DM , hypertension.
  • •3\. History of valvular heart disease, coronary artery disease.
  • •4\. Hepatocellular carcinoma
  • •5\. Pregnant females
  • •6\. History of cerebrovascular disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Treatment for renal failure in chronic liver diseaseHealth Condition 1: null- Chronic Liver Disease Hepato renal Syndrome
CTRI/2011/09/002032SKIMS university60
Not yet recruiting
Not Applicable
Role of Terlipressin in maintaning blood pressure in a patient going into shock because of sepsisHealth Condition 1: R652- Severe sepsis
CTRI/2019/10/021484Hospital Supplies AIIMS Jodhpur
Not yet recruiting
Phase 2
Comparison of Terlipressin and low dose Terlipressin and noradrenalin in HRS-AKI patients of ACLFHealth Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2023/10/058546on sponsered
Completed
Not Applicable
To compare low cost treatment regimen with standard treatment in patients with hepatorenal syndromeHealth Condition 1: null- Hepatorenal syndrome
CTRI/2011/07/001860il80
Not yet recruiting
Phase 3
Outpatient terlipressin infusion for the prevention of liver events in cirrhosis
ACTRN12624000903583Austin Health100